$25.89 Million in Sales Expected for Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) This Quarter

Retrieved on: 2021-01-01 09:22:30

Tags for this article:

Click the tags to see associated articles and topics

$25.89 Million in Sales Expected for Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) This Quarter. View article details on hiswai:

Excerpt

The biotechnology company reported ($1.46) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.95) by ($0.51).

Article found on: www.marketbeat.com